Top Banner
Heart Failure - I Heart Failure - I Pathophysiology Pathophysiology Dr Hanan ALBackr Dr Hanan ALBackr 3/11/1429 3/11/1429 (1/11/2008) (1/11/2008)
42

Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Jan 19, 2016

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Heart Failure - I Heart Failure - I PathophysiologyPathophysiology

Dr Hanan ALBackrDr Hanan ALBackr

3/11/14293/11/1429

(1/11/2008)(1/11/2008)

Page 2: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

REMEMBER LEFT REMEMBER LEFT VENTRICULAR FAILURE IS A VENTRICULAR FAILURE IS A TRUE LIFE THREATENING TRUE LIFE THREATENING EMERGENCYEMERGENCY

Page 3: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

OverviewOverview

Cardiac failure: heart unable to pump blood at a Cardiac failure: heart unable to pump blood at a rate required by tissuesrate required by tissues

Caused by:Caused by: Myocardial deathMyocardial death Myocyte dysfunctionMyocyte dysfunction Ventricular remodelingVentricular remodeling Abnormal energy utilizationAbnormal energy utilization IschemiaIschemia Neurohormonal disturbances Neurohormonal disturbances

Page 4: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Coronary artery Coronary artery disease--chronicdisease--chronic

HTN--bothHTN--both Valvular heart disease Valvular heart disease

(especially aorta and (especially aorta and mitral disease)--mitral disease)--chronicchronic

Infections--acuteInfections--acute Dysrhythmias--acuteDysrhythmias--acute

Alcohol--chronicAlcohol--chronic MI--acuteMI--acute Diabetes—chronicDiabetes—chronic

Page 5: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Etiology—Acute MI—Acute MI—

Inferior MIInferior MI

Pulmonary disease Pulmonary disease COPD, fibrosis, HTNCOPD, fibrosis, HTN

Cardiac disease Cardiac disease involving the left or both involving the left or both ventriclesventricles

Results from LVFResults from LVF

Pathophysiology—Decreased right-sided Decreased right-sided cardiac output or cardiac output or increased pulmonary increased pulmonary vascular resistance vascular resistance increased right vent. increased right vent. Pressures.Pressures.

As pressures rise, this As pressures rise, this increased pressure in increased pressure in the right atrium and the right atrium and venous systemvenous system

Higher right atrium Higher right atrium pressures pressures JVP JVP

Page 6: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Marked JVDMarked JVD Clear chestClear chest HypotensionHypotension Marked peripheral Marked peripheral

edemaedema Ascites, hepatomegalyAscites, hepatomegaly Poor exercise Poor exercise

tolerancetolerance

The first three are for The first three are for an inferior MI, an inferior MI, describe cardiac describe cardiac tamponade.tamponade.

Often will be on Lasix, Often will be on Lasix, Digoxin,Digoxin,

Have chronic pump Have chronic pump failurefailure

Page 7: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Jugular Venous DistentionJugular Venous Distention—not directly related to —not directly related to LVF. LVF.

Comes from back Comes from back pressure building from pressure building from right heart into venous right heart into venous circulationcirculation

Vital Signs—Vital Signs—Significant increase in Significant increase in sympathetic discharge to sympathetic discharge to compensate.compensate.BP—elevatedBP—elevatedPulse rate—elevated to Pulse rate—elevated to compensate for compensate for decreased stroke volume.decreased stroke volume.Respirations—rapid and Respirations—rapid and laboredlabored

Page 8: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Neurohormonal systemNeurohormonal system Renin-angiotensin-aldosterone systemRenin-angiotensin-aldosterone system Ventricular hypertrophyVentricular hypertrophy

Page 9: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

compensatory mechanismscompensatory mechanisms

Atrial underfillingAtrial underfilling Renin-Angiotensin-Aldosterone Renin-Angiotensin-Aldosterone

SystemSystem Sympathetic systemSympathetic system Natriuretic peptidesNatriuretic peptides

Page 10: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)
Page 11: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

BackgroundBackground

Heart failure pathophysiologyHeart failure pathophysiology Index eventIndex event Compensatory mechanismsCompensatory mechanisms Maladaptive mechanismsMaladaptive mechanisms

Page 12: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)
Page 13: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Body-Fluid VolumeBody-Fluid Volume

Renal Na and water excretionRenal Na and water excretion Dependent on arterial circulationDependent on arterial circulation Cardiac output and peripheral resistanceCardiac output and peripheral resistance

Decrease in circulation leads to Decrease in circulation leads to arterial arterial underfillingunderfilling Decreased effective circulating volumeDecreased effective circulating volume

NeurohormonalNeurohormonal reflexes are triggered reflexes are triggered

Page 14: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Arterial UnderfillingArterial Underfilling

Causes and consequencesCauses and consequences

Counter-regulationCounter-regulation

Page 15: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Arterial UnderfillingArterial Underfilling

MechanoreceptorsMechanoreceptors Sense arterial fillingSense arterial filling Regulate body-fluid volumeRegulate body-fluid volume LV, carotid sinus, aortic arch, renal afferentsLV, carotid sinus, aortic arch, renal afferents

Decreased activation leads toDecreased activation leads to Increase sympathetic outflowIncrease sympathetic outflow RAAS activationRAAS activation ADH release and thirst activationADH release and thirst activation

Page 16: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

High vs Low Output FailureHigh vs Low Output Failure

Majority of HF is low outputMajority of HF is low output

High output failureHigh output failure Beriberi, thyrotoxicosis, AV fistula, pregnancy Beriberi, thyrotoxicosis, AV fistula, pregnancy

etc.etc. Arterial underfilling results from arterial Arterial underfilling results from arterial

vasodilationvasodilation

Page 17: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Arterial UnderfillingArterial Underfilling

Page 18: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Sympathetic Nervous SystemSympathetic Nervous System

Increased sympathetic tone leads toIncreased sympathetic tone leads to Increased myocardial contractilityIncreased myocardial contractility TachycardiaTachycardia Arterial vasoconstriction Arterial vasoconstriction high afterload high afterload Venoconstriction Venoconstriction high preload high preload

Page 19: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Sympathetic NS & Frank-StarlingSympathetic NS & Frank-Starling

In HF, In HF, generalized generalized adrenergic adrenergic activationactivation

Reduction in Reduction in NE stores and NE stores and beta-R densitybeta-R density

Page 20: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Sympathetic NSSympathetic NS

Page 21: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Sympathetic NSSympathetic NS

Previously, beta-blockade thought to be Previously, beta-blockade thought to be contraindicatedcontraindicated

Now, one of the principal treatmentsNow, one of the principal treatments CIBIS II (bisoprolol, NYHA III-IV)CIBIS II (bisoprolol, NYHA III-IV) MERIT-HF (metoprolol, NYHA II-IV)MERIT-HF (metoprolol, NYHA II-IV) COPERNICUS (carvedilol, NYHA III-IV)COPERNICUS (carvedilol, NYHA III-IV)

Page 22: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Renin Angiotensin AldosteroneRenin Angiotensin Aldosterone

Page 23: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Renin-Angiotensin-AldosteroneRenin-Angiotensin-Aldosterone

RAAS increasedRAAS increased Degree of increase plasma renin prognosticDegree of increase plasma renin prognostic

Mild HFMild HF May have near normal renin/aldosteroneMay have near normal renin/aldosterone Inappropriate given high extracellular volumeInappropriate given high extracellular volume

Severe HFSevere HF High plasma renin and aldosteroneHigh plasma renin and aldosterone

Page 24: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

RAASRAAS

Aldosterone activity more persistent in HFAldosterone activity more persistent in HF

In normal person – high mineralocorticoidIn normal person – high mineralocorticoid Initially increases volume 1.5-2LInitially increases volume 1.5-2L Renal Na retention then plateausRenal Na retention then plateaus Usually no detectable edemaUsually no detectable edema

Plateau does not occur in HFPlateau does not occur in HF

Page 25: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

RAASRAAS

Page 26: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Angiotensin IIAngiotensin II

Increases aldosterone secretionIncreases aldosterone secretionIncreases proximal Na reabsorptionIncreases proximal Na reabsorptionVasoconstriction of renal arteriolesVasoconstriction of renal arteriolesStimulates central thirstStimulates central thirst

May also have mitogenic effect on myocytesMay also have mitogenic effect on myocytes Decrease in capillary network relative to myocardiumDecrease in capillary network relative to myocardium

Page 27: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Arginine VasopressinArginine Vasopressin

Leads to edema and hyponatremiaLeads to edema and hyponatremia

Ominous prognostic indicatorOminous prognostic indicator

Nonosmostic release of ADHNonosmostic release of ADH Carotid baroreceptor activationCarotid baroreceptor activation

V2-receptors: upregulates aquaporins in CDV2-receptors: upregulates aquaporins in CD

V1-receptors: in vascular smooth ms; V1-receptors: in vascular smooth ms; contributes to cardiac dysfxncontributes to cardiac dysfxn

Page 28: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Natriuretic PeptidesNatriuretic Peptides

Atrial natriuretic peptideAtrial natriuretic peptide Synthesized in atria > ventriclesSynthesized in atria > ventricles Released into circulation during atrial Released into circulation during atrial

distentiondistention Increased in HF as atrial pressures riseIncreased in HF as atrial pressures rise

Brain natriuretic peptideBrain natriuretic peptide Synthesized primarily in ventriclesSynthesized primarily in ventricles Increased in early LV dysfxnIncreased in early LV dysfxn

Page 29: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Natriuretic PeptidesNatriuretic Peptides

Atrial NP and BNPAtrial NP and BNP Causes renal efferent V/C and afferent V/DCauses renal efferent V/C and afferent V/D GFR risesGFR rises Decreases Na reabsorption in CDDecreases Na reabsorption in CD Inhibits secretion of renin and aldosteroneInhibits secretion of renin and aldosterone

In HF, develop resistance to natriuretic effectIn HF, develop resistance to natriuretic effect Down-regulation of receptorsDown-regulation of receptors Increased degradation of peptides by endopeptidaseIncreased degradation of peptides by endopeptidase

Page 30: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

RAAS vs Natriuretic PeptidesRAAS vs Natriuretic Peptides

Page 31: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Endothelial HormonesEndothelial Hormones

Prostacyclin and PG EProstacyclin and PG E Autocrine hormones in glomerular afferents: V/DAutocrine hormones in glomerular afferents: V/D Stimulated by Angiotenin II, NEStimulated by Angiotenin II, NE Counterbalance neurohormone-induced V/CCounterbalance neurohormone-induced V/C

Nitric oxideNitric oxide Potent V/DPotent V/D NO synthase blunted in HFNO synthase blunted in HF

EndothelinEndothelin Potent V/CPotent V/C Increased in HF Increased in HF poor prognostic indicator poor prognostic indicator

Page 32: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Summary of EffectsSummary of Effects

Page 33: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Chronic Myocardial RemodelingChronic Myocardial Remodeling

Page 34: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

RemodelingRemodeling

Pressure OverloadPressure Overload

Increase in Increase in systolicsystolic wall stresswall stress

ParallelParallel replication of replication of myofibrilsmyofibrils

ThickeningThickening of of myocytesmyocytes

Small increase in Small increase in number of myocytesnumber of myocytes

Volume OverloadVolume Overload

Increase in Increase in diastolicdiastolic wall stresswall stress

Replication of Replication of sarcomeres in sarcomeres in seriesseries

ElongationElongation of of myoctytesmyoctytes

Ventricular Ventricular dilatationdilatation

Page 35: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Stages of Cardiac HypertrophyStages of Cardiac Hypertrophy

Page 36: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Laplace’s LawLaplace’s Law

Page 37: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Transition to HFTransition to HF

Stress on ventricleStress on ventricle Acute adaptive compensatory mechanismsAcute adaptive compensatory mechanisms

Hemodynamic overload severe / Hemodynamic overload severe / prolongedprolonged Contractility depressedContractility depressed Depressed intramural myocardial shorteningDepressed intramural myocardial shortening

Page 38: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Molecular MechanismsMolecular Mechanisms

Page 39: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Molecular MechanismsMolecular Mechanisms

Myocyte lossMyocyte loss Causes decreased contractile fxnCauses decreased contractile fxn

1.1. NecrosisNecrosis Occurs with O2 / energy deprivationOccurs with O2 / energy deprivation Loss of membrane integrityLoss of membrane integrity Influx of extracellular fluid Influx of extracellular fluid cellular cellular

disruptiondisruption

Page 40: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

Molecular MechanismsMolecular Mechanisms

2.2. ApoptosisApoptosisProgrammed cell deathProgrammed cell deathEnergy-dependent processEnergy-dependent processInvolution of myocyte Involution of myocyte phagocytosis by phagocytosis by neighbouring cellneighbouring cell

Increasing evidence of role in HFIncreasing evidence of role in HFCatecholamines, A II, NO, cytokines, Catecholamines, A II, NO, cytokines, mechanical strainmechanical strain

Page 41: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

SummarySummary

Pathophysiology based on compensatory Pathophysiology based on compensatory mechanisms becoming maladaptivemechanisms becoming maladaptive

Key players:Key players: Atrial underfillingAtrial underfilling Renin-Angiotensin-Aldosterone SystemRenin-Angiotensin-Aldosterone System Sympathetic systemSympathetic system Natriuretic peptidesNatriuretic peptides

Leads to chronic remodelling via apoptosis and Leads to chronic remodelling via apoptosis and necrosisnecrosis

Page 42: Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)

In conclusion, congestive In conclusion, congestive heart failure is often assumed heart failure is often assumed to be a disease when in fact it to be a disease when in fact it

is a syndrome caused by is a syndrome caused by multiple disorders.multiple disorders.